These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28521187)

  • 1. Brain antioxidant effect of mirtazapine and reversal of sedation by its combination with alpha-lipoic acid in a model of depression induced by corticosterone.
    Oliveira TQ; de Sousa CNS; Vasconcelos GS; de Sousa LC; de Oliveira AA; Patrocínio CFV; Medeiros IDS; Honório Júnior JER; Maes M; Macedo D; Vasconcelos SMM
    J Affect Disord; 2017 Sep; 219():49-57. PubMed ID: 28521187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice.
    Silva MC; de Sousa CN; Gomes PX; de Oliveira GV; Araújo FY; Ximenes NC; da Silva JC; Vasconcelos GS; Leal LK; Macêdo D; Vasconcelos SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():142-8. PubMed ID: 26265141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of corticosterone-induced BDNF alterations by the natural antioxidant alpha-lipoic acid alone and combined with desvenlafaxine: Emphasis on the neurotrophic hypothesis of depression.
    de Sousa CN; Meneses LN; Vasconcelos GS; Silva MC; da Silva JC; Macêdo D; de Lucena DF; Vasconcelos SM
    Psychiatry Res; 2015 Dec; 230(2):211-9. PubMed ID: 26350703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression.
    de Sousa CNS; Meneses LN; Vasconcelos GS; da Silva Medeiros I; Silva MCC; Mouaffak F; Kebir O; da Silva Leite CMG; Patrocinio MCA; Macedo D; Vasconcelos SMM
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Aug; 391(8):803-817. PubMed ID: 29732526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoic acid prevents mirtazapine-induced weight gain in mice without impairs its antidepressant-like action in a neuroendocrine model of depression.
    Oliveira TQ; Chaves Filho AJM; Jucá PM; Soares MVR; Cunha NL; Vieira CFX; Gadelha Filho CVJ; Viana GA; De Oliveira GMF; Macedo DS; Vasconcelos SMM
    Behav Brain Res; 2022 Feb; 419():113667. PubMed ID: 34798169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms.
    Lopes IS; Oliveira ICM; Capibaribe VCC; Valentim JT; da Silva DMA; de Souza AG; de Araújo MA; Chaves RC; Gutierrez SJC; Barbosa Filho JM; Macêdo DS; de Sousa FCF
    Neurochem Int; 2018 Nov; 120():33-42. PubMed ID: 30041016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine.
    Macêdo DS; Medeiros CD; Cordeiro RC; Sousa FC; Santos JV; Morais TA; Hyphantis TN; McIntyre RS; Quevedo J; Carvalho AF
    Bipolar Disord; 2012 Nov; 14(7):707-18. PubMed ID: 22897629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice.
    Sulakhiya K; Kumar P; Jangra A; Dwivedi S; Hazarika NK; Baruah CC; Lahkar M
    Eur J Pharmacol; 2014 Dec; 744():124-31. PubMed ID: 25446914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation therapy with alpha-lipoic acid and desvenlafaxine: a future target for treatment of depression?
    Silva MC; de Sousa CN; Sampaio LR; Ximenes NC; Araújo PV; da Silva JC; de Oliveira SL; Sousa FC; Macêdo DS; Vasconcelos SM
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):685-95. PubMed ID: 23584634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of Myrcia pubipetala Miq. against the alterations in oxidative stress parameters in an animal model of depression induced by corticosterone.
    Shuster AL; Rocha FE; Wayszceyk S; de Lima DD; Barauna SC; Lopes BG; Alberton MD; Magro DDD
    Brain Res; 2022 Jan; 1774():147725. PubMed ID: 34785258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice.
    Gupta D; Radhakrishnan M; Kurhe Y
    Steroids; 2015 Apr; 96():95-102. PubMed ID: 25668613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin reverses corticosterone-induced depression-like behavior, decrease in hippocampal brain-derived neurotrophic factor (BDNF) and metabolic network disturbances revealed by NMR-based metabonomics in rats.
    Gong MJ; Han B; Wang SM; Liang SW; Zou ZJ
    J Pharm Biomed Anal; 2016 May; 123():63-73. PubMed ID: 26874256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice.
    Kv A; Madhana RM; Js IC; Lahkar M; Sinha S; Naidu VGM
    Behav Brain Res; 2018 May; 344():73-84. PubMed ID: 29452193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress.
    Moretti M; Colla A; de Oliveira Balen G; dos Santos DB; Budni J; de Freitas AE; Farina M; Severo Rodrigues AL
    J Psychiatr Res; 2012 Mar; 46(3):331-40. PubMed ID: 22154133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice.
    Ali SH; Madhana RM; K V A; Kasala ER; Bodduluru LN; Pitta S; Mahareddy JR; Lahkar M
    Steroids; 2015 Sep; 101():37-42. PubMed ID: 26048446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peony glycosides reverse the effects of corticosterone on behavior and brain BDNF expression in rats.
    Mao QQ; Huang Z; Ip SP; Xian YF; Che CT
    Behav Brain Res; 2012 Feb; 227(1):305-9. PubMed ID: 22119711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice.
    Chaves RC; Mallmann ASV; Oliveira NF; Oliveira ICM; Capibaribe VCC; da Silva DMA; Lopes IS; Valentim JT; de Carvalho AMR; Macêdo DS; Vasconcelos SMM; Gutierrez SJC; Barbosa Filho JM; de Sousa FCF
    Pharmacol Biochem Behav; 2019 May; 180():44-51. PubMed ID: 30904544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecalciferol counteracts depressive-like behavior and oxidative stress induced by repeated corticosterone treatment in mice.
    Camargo A; Dalmagro AP; Rikel L; da Silva EB; Simão da Silva KAB; Zeni ALB
    Eur J Pharmacol; 2018 Aug; 833():451-461. PubMed ID: 29981295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in rats.
    Huang Z; Zhong XM; Li ZY; Feng CR; Pan AJ; Mao QQ
    Neurosci Lett; 2011 Apr; 493(3):145-8. PubMed ID: 21334417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.